Page last updated: 2024-09-05

regadenoson and Chronic Liver Failure

regadenoson has been researched along with Chronic Liver Failure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmed, A; Ahmed, D; Al-Mallah, M; Alali Alfaris, M; Alharthi, M; Aljizeeri, A; Alsaileek, A; Elneama, A; Farea, J; Suliman, I	1

Other Studies

1 other study(ies) available for regadenoson and Chronic Liver Failure

Article	Year
Are Patients With End-Stage Liver Disease Maximally Vasodilated?: Insights From Rubidium-82 PET Dilatory Perfusion. JACC. Cardiovascular imaging, 2019, Volume: 12, Issue:12 Topics: Aged; Coronary Artery Disease; Dipyridamole; End Stage Liver Disease; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Retrospective Studies; Rubidium Radioisotopes; Vasodilation; Vasodilator Agents	2019

Article

Year

Are Patients With End-Stage Liver Disease Maximally Vasodilated?: Insights From Rubidium-82 PET Dilatory Perfusion.

JACC. Cardiovascular imaging, 2019, Volume: 12, Issue:12

Topics: Aged; Coronary Artery Disease; Dipyridamole; End Stage Liver Disease; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Retrospective Studies; Rubidium Radioisotopes; Vasodilation; Vasodilator Agents

2019